This notion of lowering the activation threshold required for kinase activation, rather than resulting in constitutive activity, is also exemplified by recently described mutations in the MET kinase N-lobe identified in patients with hereditary papillary renal cell carcinoma [67]; the mutant receptors remain dependent on HGF activation to drive tumorigenesis. Here, HGF is linked to papillary renal cell carcinoma.